Research guide

Thymosin alpha-1

Thymalfasin · Zadaxin

Also called thymalfasin, a peptide studied for immune-related conditions.

Compare
Product statusUnapproved / RUO
Development snapshotNot FDA approved

How it works, simply

It influences parts of innate and adaptive immune signaling.

What the evidence tells us

Indications and regulatory status differ internationally; immune activity does not establish a general immune-boosting benefit.

Watch with PEP 7

A short introduction; the sources and limitations remain important.

Open video guide

Video guides are coming soon.

Risks and open questions

This guide does not establish a safe dose, interaction profile or long-term safety for self-use. Effects reported for one route or formulation may not apply to another.

Research and education only. PepGuide does not recommend medicines, doses or protocols.

Technical details and study context

Mechanism: Modulates innate and adaptive immune pathways; regulatory context varies internationally.

Sponsor or developer: Multiple international developers

Studied or labeled topics: Immune modulation, Infectious disease research

Commercial blend names and research vials do not inherit a medicine’s approval or manufacturing controls.

Sources and review dates

Product labels and further research

These directories help locate records. They are not individual studies supporting every statement.

Readability updated October 10, 2026. Evidence review: October 10, 2026 (FDA safety context only). A wording update is not a new clinical review.